These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19122539)

  • 21. Report on the fifth consensus conference: methodology of long-term clinical trials in psychiatry.
    Angst J; Bech P; Bruinvels J; Engel RR; Ferner U; Guelfi JD; Lingjaerde O; Müller-Oerlinghausen B; Paes de Sousa M; Paykel E
    Pharmacopsychiatry; 1994 May; 27(3):101-7. PubMed ID: 8078950
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of benzodiazepines: do they work or not?
    Lader M
    Expert Rev Neurother; 2008 Aug; 8(8):1189-91. PubMed ID: 18671662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duloxetine in the treatment of generalized anxiety disorder.
    Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG
    Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonazepam in the treatment of psychiatric disorders: an update.
    Nardi AE; Perna G
    Int Clin Psychopharmacol; 2006 May; 21(3):131-42. PubMed ID: 16528135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current use of benzodiazepines in anxiety disorders.
    Cloos JM; Ferreira V
    Curr Opin Psychiatry; 2009 Jan; 22(1):90-5. PubMed ID: 19122540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-site findings in a study of the safety and efficacy of a CCKB receptor antagonist, CI-988, in the treatment of generalized anxiety disorder.
    Sramek JJ; Costa JF; Adams JB; Macpherson A; Cutler NR
    Anxiety; 1994-1995; 1(5):242-3. PubMed ID: 9160582
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of anxiety disorders in older adults: a meta-analytic comparison of behavioral and pharmacological interventions.
    Pinquart M; Duberstein PR
    Am J Geriatr Psychiatry; 2007 Aug; 15(8):639-51. PubMed ID: 17670995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anxiety disorders: long-term treatment and replapse prevention].
    Bandelow VB; Wolff-Menzler C; Wedekind D; Rüther E
    MMW Fortschr Med; 2006 Jan; 148(4):31-4. PubMed ID: 16502797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of anxiety in the medically ill patient.
    Rubey RN; Lydiard RB
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):133-47. PubMed ID: 10378956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
    Baldwin DS; Anderson IM; Nutt DJ; Bandelow B; Bond A; Davidson JR; den Boer JA; Fineberg NA; Knapp M; Scott J; Wittchen HU;
    J Psychopharmacol; 2005 Nov; 19(6):567-96. PubMed ID: 16272179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal and dietary supplements for treatment of anxiety disorders.
    Saeed SA; Bloch RM; Antonacci DJ
    Am Fam Physician; 2007 Aug; 76(4):549-56. PubMed ID: 17853630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse rates with long-term antidepressant drug therapy: a meta-analysis.
    Williams N; Simpson AN; Simpson K; Nahas Z
    Hum Psychopharmacol; 2009 Jul; 24(5):401-8. PubMed ID: 19526453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalized anxiety disorder: between now and DSM-V.
    Allgulander C
    Psychiatr Clin North Am; 2009 Sep; 32(3):611-28. PubMed ID: 19716993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term treatment of depression: there is more than drugs].
    Fava GA; Ruini C
    Recenti Prog Med; 2002 Jun; 93(6):343-5. PubMed ID: 12085711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceived group climate as a predictor of long-term outcome in a randomized controlled trial of cognitive-behavioural group therapy for patients with comorbid psychiatric disorders.
    Ryum T; Hagen R; Nordahl HM; Vogel PA; Stiles TC
    Behav Cogn Psychother; 2009 Oct; 37(5):497-510. PubMed ID: 19664320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].
    Lehmann E; Hassel P; Thörner GW; Karrass W
    Fortschr Med; 1984 Oct; 102(40):1033-6. PubMed ID: 6149989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacotherapy of anxiety disorders].
    Bitter I
    Orv Hetil; 1995 Nov; 136(45):2435-9. PubMed ID: 8524548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitomycin C and the endoscopic treatment of laryngotracheal stenosis: are two applications better than one?
    Smith ME; Elstad M
    Laryngoscope; 2009 Feb; 119(2):272-83. PubMed ID: 19160408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on partial response in depression.
    Thase ME
    J Clin Psychiatry; 2009; 70 Suppl 6():4-9. PubMed ID: 19922738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders.
    Serretti A; Chiesa A; Calati R; Perna G; Bellodi L; De Ronchi D
    Int Clin Psychopharmacol; 2009 Jan; 24(1):1-18. PubMed ID: 19060722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.